Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Platt

Showing results (401-410 of 505) with videos related to

Pageof 51
Sort By:
Annals of the Rheumatic Diseases|September 13, 2011
Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and Toll-like receptor ligand stimulationM H Wenink, K C M Santegoets, A M Platt, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2011
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viabilityDavid R Wise, Patrick S Ward, Jessica E S Shay, et al.
Brain Communications|March 19, 2021
Acetyl-leucine slows disease progression in lysosomal storage disordersEcem Kaya, David A Smith, Claire Smith, et al.
Acta Neuropathologica Communications|August 9, 2020
Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicityOeystein R Brekk, Joanna A Korecka, Cecile C Crapart, et al.
HIV Medicine|June 5, 2019
Towards person-centred care for people living with HIV: what core outcomes matter, and how might we assess them? A cross-national multi-centre qualitative study with key stakeholdersK Bristowe, P Clift, R James, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 13, 2015
High incidence of unrecognized visceral/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data setsChristopher A Wassif, Joanna L Cross, James Iben, et al.
The Journal of Biological Chemistry|July 25, 2013
β-Glucosidase 2 (GBA2) activity and imino sugar pharmacologyChristina M Ridley, Karen E Thur, Jessica Shanahan, et al.
Life Science Alliance|June 4, 2020
Unbiased yeast screens identify cellular pathways affected in Niemann-Pick disease type CAlexandria Colaco, María E Fernández-Suárez, Dawn Shepherd, et al.
Plos Biology|July 3, 2025
Plasma membrane remodeling in GM2 gangliosidoses drives synaptic dysfunctionAlex S Nicholson, David A Priestman, Robin Antrobus, et al.
Journal of Inherited Metabolic Disease|October 27, 2004
Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher diseaseD Elstein, C Hollak, J M F G Aerts, et al.
Pageof 51

Showing results (401-410 of 505) with videos related to

Sort By:
Pageof 51
Annals of the Rheumatic Diseases|September 13, 2011
Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and Toll-like receptor ligand stimulationM H Wenink, K C M Santegoets, A M Platt, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2011
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viabilityDavid R Wise, Patrick S Ward, Jessica E S Shay, et al.
Brain Communications|March 19, 2021
Acetyl-leucine slows disease progression in lysosomal storage disordersEcem Kaya, David A Smith, Claire Smith, et al.
Acta Neuropathologica Communications|August 9, 2020
Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicityOeystein R Brekk, Joanna A Korecka, Cecile C Crapart, et al.
HIV Medicine|June 5, 2019
Towards person-centred care for people living with HIV: what core outcomes matter, and how might we assess them? A cross-national multi-centre qualitative study with key stakeholdersK Bristowe, P Clift, R James, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 13, 2015
High incidence of unrecognized visceral/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data setsChristopher A Wassif, Joanna L Cross, James Iben, et al.
The Journal of Biological Chemistry|July 25, 2013
β-Glucosidase 2 (GBA2) activity and imino sugar pharmacologyChristina M Ridley, Karen E Thur, Jessica Shanahan, et al.
Life Science Alliance|June 4, 2020
Unbiased yeast screens identify cellular pathways affected in Niemann-Pick disease type CAlexandria Colaco, María E Fernández-Suárez, Dawn Shepherd, et al.
Plos Biology|July 3, 2025
Plasma membrane remodeling in GM2 gangliosidoses drives synaptic dysfunctionAlex S Nicholson, David A Priestman, Robin Antrobus, et al.
Journal of Inherited Metabolic Disease|October 27, 2004
Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher diseaseD Elstein, C Hollak, J M F G Aerts, et al.
Pageof 51